Metoprolol and propranolol are both beta blockers, but they work differently in the body because they target different receptors. Metoprolol is selective, focusing primarily on the heart. Propranolol is nonselective, blocking beta receptors throughout the body, including in the lungs, blood vessels, and brain. That core distinction drives nearly every practical difference between them: which conditions they treat, who can safely take them, and what side effects to expect.
How They Work in the Body
Your body has two main types of beta receptors. Beta-1 receptors sit mostly in the heart, where they control heart rate and the force of each heartbeat. Beta-2 receptors are spread across the lungs, blood vessels, and other tissues, where they help relax airway muscles and regulate blood sugar.
Metoprolol is a second-generation beta blocker with dose-dependent selectivity for beta-1 receptors. At typical doses, it mainly slows the heart and lowers blood pressure without much effect on the lungs or peripheral blood vessels. That selectivity isn’t absolute, though. At higher doses, it starts blocking beta-2 receptors too.
Propranolol is a first-generation beta blocker that blocks both beta-1 and beta-2 receptors equally. Because it reaches receptors throughout the body, it has a broader range of effects. It slows the heart, but it also dampens the physical symptoms of adrenaline everywhere: trembling hands, racing pulse, sweating. That whole-body reach is exactly why propranolol gets prescribed for conditions well beyond the heart.
Conditions Each One Treats
Both drugs are used for high blood pressure, chest pain from angina, atrial fibrillation, migraine prevention, and reducing mortality after a heart attack. The overlap is significant, but each drug has territory the other doesn’t cover well.
Metoprolol’s biggest distinction is in heart failure. The sustained-release form (metoprolol succinate) is one of only three beta blockers shown to reduce the risk of death in people with heart failure with reduced ejection fraction, according to the 2022 AHA/ACC/HFSA guidelines. Propranolol is not recommended for this purpose. If you’ve been prescribed a beta blocker specifically for heart failure, metoprolol succinate (or bisoprolol or carvedilol) is the standard choice.
Propranolol covers a much wider list of non-cardiac conditions. It’s used for performance anxiety and stage fright, essential tremor, panic disorder, thyroid storm, portal hypertension (a complication of liver disease), and even infantile hemangiomas (a type of blood vessel growth in babies). Its ability to block the physical symptoms of anxiety, like shaking, rapid heartbeat, and sweating, makes it popular among musicians, public speakers, and others facing high-pressure situations. Metoprolol is not typically prescribed for anxiety because its heart-focused action doesn’t quiet those widespread adrenaline symptoms as effectively.
Why Lung Health Matters
This is where receptor selectivity becomes very practical. Because propranolol blocks beta-2 receptors in the lungs, it can tighten the airways. For someone with asthma or COPD, that’s a real concern. Beta blockers have historically been underused in people with COPD and coexisting heart failure precisely because of worries about triggering bronchoconstriction.
Metoprolol’s selectivity for beta-1 receptors makes it a safer option for people with respiratory conditions, since it largely spares the airway receptors at standard doses. That said, metoprolol’s selectivity ratio (beta-1 to beta-2) is about 2.3, which is moderate. Bisoprolol, another selective beta blocker, has a ratio of 13.3, making it even more lung-friendly. So if you have significant asthma or COPD, the choice of beta blocker and the dose both matter.
Side Effects
Both drugs share common beta blocker side effects: fatigue, dizziness, slow heart rate, and low blood pressure. The differences come from propranolol’s broader reach.
Because propranolol blocks beta-2 receptors in blood vessels, it’s more likely to cause cold hands and feet from reduced circulation. It can also worsen blood sugar control, which matters if you have diabetes, because beta-2 receptors play a role in glucose regulation. Some people on propranolol report more vivid dreams or sleep disturbances, likely related to its ability to cross into the brain more readily.
Metoprolol’s side effects tend to center on the heart: too-slow heart rate, lightheadedness when standing, and fatigue. It’s generally better tolerated in people with circulation issues or diabetes, though it’s not completely free of metabolic effects.
How They’re Metabolized
Both drugs are broken down in the liver, but they rely on different enzyme pathways, which affects how they interact with other medications.
Metoprolol is primarily processed by a liver enzyme called CYP2D6, which handles roughly 80% of its breakdown. About 5 to 10% of people of European descent are “poor metabolizers” of CYP2D6, meaning the drug stays in their system longer and hits harder at standard doses. If you take other medications that inhibit CYP2D6 (certain antidepressants are common culprits), metoprolol levels can rise significantly.
Propranolol is also metabolized in the liver but through multiple enzyme pathways, making it somewhat less dependent on any single one. It still has plenty of drug interactions, particularly with medications that affect liver blood flow or compete for the same enzymes, but the CYP2D6 genetic factor is less dominant than with metoprolol.
Dosing and Forms
Metoprolol comes in two formulations that are not interchangeable. Metoprolol tartrate is the immediate-release version, typically taken two to four times daily. Metoprolol succinate is the extended-release version, designed for once-daily dosing. Both have a plasma half-life of roughly 3 to 7 hours, but the extended-release tablet controls the drug’s release to maintain steady levels throughout the day.
Propranolol also comes in immediate-release and extended-release forms. The immediate-release version has a half-life of 3 to 6 hours and is often taken two to three times daily for ongoing conditions, or as a single dose before a stressful event for performance anxiety. The extended-release capsule allows once-daily dosing.
Choosing Between Them
The right choice depends on what condition is being treated. For heart failure with reduced ejection fraction, metoprolol succinate is one of the guideline-recommended options. For straightforward high blood pressure or angina in someone without lung disease, either drug works, though metoprolol is prescribed more often in cardiac settings.
For performance anxiety, tremor, migraine prevention, or conditions where you need to calm the body’s full adrenaline response, propranolol is the more common pick. Its nonselective action is a feature, not a bug, for these uses. If you have asthma or COPD, metoprolol is generally preferred because it’s less likely to tighten the airways, though even selective beta blockers require careful monitoring in people with significant lung disease.
Both medications are inexpensive generics that have been used for decades. The choice often comes down to one question: do you need a beta blocker that focuses on the heart, or one that quiets adrenaline throughout the entire body?